NETWORK MEDICINES Trademark

Trademark Overview


On Tuesday, May 16, 2023, a trademark application was filed for NETWORK MEDICINES with the United States Patent and Trademark Office. The USPTO has given the NETWORK MEDICINES trademark a serial number of 97939283. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, July 5, 2024. This trademark is owned by Sonata Therapeutics, Inc.. The NETWORK MEDICINES trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation

Regenerative medicine services

Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals
network medicines

General Information


Serial Number97939283
Word MarkNETWORK MEDICINES
Filing DateTuesday, May 16, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, July 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation
Goods and ServicesRegenerative medicine services
Goods and ServicesScientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSonata Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Thursday, June 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 30, 2023NON-FINAL ACTION WRITTEN
Thursday, November 30, 2023NON-FINAL ACTION E-MAILED
Thursday, November 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 21, 2024NON-FINAL ACTION WRITTEN
Thursday, March 21, 2024NON-FINAL ACTION E-MAILED
Thursday, March 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 5, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 5, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND